Organization
The Medical Department, Jiangsu Simcere Diagnostics Co., Ltd.
7 abstracts
Abstract
Alterations of the tumor microenvironment (TME) in recurrent glioblastoma following apatinib in combination with temozolomide.Org: The Medical Department, Jiangsu Simcere Diagnostics Co., Ltd.,
Abstract
Early-stage lung adenocarcinoma with a micropapillary pattern showing a distinct immunogenic tumor microenvironment.Org: Shengjing Hospital of China Medical University, The Medical Department, Jiangsu Simcere Diagnostics Co., Ltd., Jiangsu Simcere Diagnostics Co., Ltd., Nanjing Simcere Medical Laboratory Science Co., Ltd., Nanjing Simcere Medical Laboratory Science Co., Ltd., The State Key Laboratory of Neurology and Oncology Drug Development, Nanjing, China,
Abstract
Investigation of synthetic lethality gene pairs in the DNA damage response pathway in response to immunotherapy in pan-cancer.Org: Department of Oncology and Haematology, Division of Oncology, University Hospital of Modena, Modena, Italy, Beijing Shijitan Hospital, Capital Medical University, The Medical Department, Jiangsu Simcere Diagnostics Co., Ltd., 3D Medicine Inc.,
Abstract
Comparison of gene alterations detected with tumor tissue and plasma in a Chinese population with advanced lung adenocarcinoma.Org: Jiangsu simcere diagnostics Co,.Ltd, The Bioinformatics Department, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing Simcere Medical Laboratory Science Co., Ltd., Nanjing Simcere Medical Laboratory Science Co., Ltd., The State Key Lab of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing, China,
Abstract
Diverse genomic characterization of Chinese patients with osteosarcoma and soft tissue sarcoma.Org: The Orthopaedic Oncology Department, Shanghai General Hospital, Shanghai, China, Gracell Biotechnologies, Ltd., The Medical Department, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing Simcere Medical Laboratory Science Co., Ltd.,
Abstract
Role of synthetic lethal mutations for the immune response: Exploratory studies of two non-small cell lung cancer cohorts and two pan-cancer cohorts.Org: Department of Thoracic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China, Department of Thoracic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China, Guangzhou, China, Geneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, China, Nanfang Hospital, Southern Medical University, Guangzhou, China, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China, The Medical Department, Jiangsu Simcere Diagnostics Co., Ltd., 3D Medicine Inc.,
Abstract
Tumor immune microenvironment (TIME) analysis of stage I lung adenocarcinoma with micropapillary pattern.Org: Shengjing Hospital of China Medical University, The Medical Department, Jiangsu Simcere Diagnostics Co., Ltd., Jiangsu Simcere Diagnostics Co., Ltd., Nanjing Simcere Medical Laboratory Science Co., Ltd., Nanjing Simcere Medical Laboratory Science Co., Ltd., The State Key Lab of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing, China,